“…Salbutamol, a f2-adrenergic receptor agonist has been shown to improve left ventricular function in patients with acute low cardiac output syndromes (Lal, Savidge, Davies Ali & Soni, 1972;Yacoub & Boyland, 1973;Wyse, Gibson & Branthwaite, 1974) and chronic congestive cardiac failure (Sharma, Goodwin & Steiner, 1977). This agent has a relatively prolonged duration of action after intravenous administration which is a disadvantage in the management of acutely ill patients with cardiac failure.…”